Open Access
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher Jl Murray
,
Kevin Shunji Ikuta
,
Fablina Sharara
,
Lucien Swetschinski
,
Gisela Robles Aguilar
,
Authia Gray
,
Chieh Han
,
Catherine Bisignano
,
Puja Rao
,
Eve Wool
,
Sarah C Johnson
,
Annie J Browne
,
Michael Give Chipeta
,
Frederick Fell
,
Sean Hackett
,
Georgina Haines Woodhouse
,
Bahar H Kashef Hamadani
,
Emmanuelle A. P. Kumaran
,
Barney Mcmanigal
,
Ramesh Agarwal
,
Samuel Akech
,
Samuel Albertson
,
John Amuasi
,
Jason Andrews
,
Aleskandr Aravkin
,
Elizabeth Ashley
,
Freddie Bailey
,
Stephen Baker
,
Buddha Basnyat
,
Adrie Bekker
,
Rose Bender
,
Bethou Adhisivam
,
Julia Bielicki
,
Suppawat Boonkasidecha
,
James Bukosia
,
Cristina Carvalheiro
,
Carlos Castañeda Orjuela
,
Vilada Chansamouth
,
Suman Chaurasia
,
Sara Chiurchiù
,
Fazle Chowdhury
,
Aislinn J Cook
,
Ben Cooper
,
Tim R. Cressey
,
Elia Criollo Mora
,
Matthew Cunningham
,
Saffiatou Darboe
,
Nicholas P.J. Day
,
Maia De Luca
,
Klara Dokova
,
Angela Dramowski
,
Susanna J Dunachie
,
Tim Eckmanns
,
Daniel Eibach
,
Amir Emami
,
Nicholas Feasey
,
Natasha Fisher Pearson
,
Karen Forrest
,
Denise Garrett
,
Petra Gastmeier
,
Ababi Zergaw Giref
,
Rachel Claire Greer
,
Vikas Gupta
,
Sebastian Haller
,
Andrea Haselbeck
,
Simon I. Hay
,
Marianne Holm
,
Susan Hopkins
,
Kenneth C. Iregbu
,
Jan Jacobs
,
Daniel Jarovsky
,
Fatemeh Javanmardi
,
Meera Khorana
,
Niranjan Kissoon
,
Elsa Kobeissi
,
Tomislav Kostyanev
,
Fiorella Krapp
,
Ralf Krumkamp
,
Ajay Kumar
,
Hmwe Hmwe Kyu
,
Cherry Lim
,
Direk Limmathurotsakul
,
Michael James Loftus
,
Miles Lunn
,
Jianing Ma
,
Neema Mturi
,
Tatiana Munera Huertas
,
Patrick Musicha
,
Marisa Marcia Mussi-Pinhata
,
Tomoka Nakamura
,
Ruchi Nanavati
,
Sushma Nangia
,
Paul Newton
,
Chanpheaktra Ngoun
,
Amanda Novotney
,
Davis Nwakanma
,
Christina W Obiero
,
Antonio Olivas-Martinez
,
Piero Olliaro
,
Ednah Ooko
,
Edgar Ortiz-Brizuela
,
Anton Yariv Peleg
,
Carlo Perrone
,
Nishad Plakkal
,
Alfredo Ponce de Leon
,
Mathieu Raad
,
Tanusha Ramdin
,
Amy Riddell
,
Tamalee Roberts
,
Julie Victoria Robotham
,
Anna Roca
,
Kristina E Rudd
,
Neal Russell
,
Jesse Schnall
,
John Anthony Gerard Scott
,
Madhusudhan Shivamallappa
,
Jose Sifuentes Osornio
,
Nicolas Steenkeste
,
Andrew James Stewardson
,
Temenuga Stoeva
,
Nidanuch Tasak
,
Areerat Thaiprakong
,
Guy Thwaites
,
Claudia Turner
,
Paul Turner
,
H. Rogier van Doorn
,
Sithembiso Velaphi
,
Avina Vongpradith
,
Huong Vu
,
Timothy Walsh
,
Seymour Waner
,
Tri Wangrangsimakul
,
Teresa Wozniak
,
Zheng Peng
,
Benn Sartorius
,
Alan D. Lopez
,
ANDY STERGACHIS
,
Catrin Moore
,
Christiane Dolecek
,
Mohsen Naghavi
Тип публикации: Journal Article
Дата публикации: 2022-02-01
scimago Q1
wos Q1
БС1
SJR: 12.113
CiteScore: 87.6
Impact factor: 88.5
ISSN: 01406736, 1474547X
PubMed ID:
35065702
General Medicine
Краткое описание
Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date.We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 23 pathogens and 88 pathogen-drug combinations in 204 countries and territories in 2019. We obtained data from systematic literature reviews, hospital systems, surveillance systems, and other sources, covering 471 million individual records or isolates and 7585 study-location-years. We used predictive statistical modelling to produce estimates of AMR burden for all locations, including for locations with no data. Our approach can be divided into five broad components: number of deaths where infection played a role, proportion of infectious deaths attributable to a given infectious syndrome, proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antibiotic of interest, and the excess risk of death or duration of an infection associated with this resistance. Using these components, we estimated disease burden based on two counterfactuals: deaths attributable to AMR (based on an alternative scenario in which all drug-resistant infections were replaced by drug-susceptible infections), and deaths associated with AMR (based on an alternative scenario in which all drug-resistant infections were replaced by no infection). We generated 95% uncertainty intervals (UIs) for final estimates as the 25th and 975th ordered values across 1000 posterior draws, and models were cross-validated for out-of-sample predictive validity. We present final estimates aggregated to the global and regional level.On the basis of our predictive statistical models, there were an estimated 4·95 million (3·62-6·57) deaths associated with bacterial AMR in 2019, including 1·27 million (95% UI 0·911-1·71) deaths attributable to bacterial AMR. At the regional level, we estimated the all-age death rate attributable to resistance to be highest in western sub-Saharan Africa, at 27·3 deaths per 100 000 (20·9-35·3), and lowest in Australasia, at 6·5 deaths (4·3-9·4) per 100 000. Lower respiratory infections accounted for more than 1·5 million deaths associated with resistance in 2019, making it the most burdensome infectious syndrome. The six leading pathogens for deaths associated with resistance (Escherichia coli, followed by Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) were responsible for 929 000 (660 000-1 270 000) deaths attributable to AMR and 3·57 million (2·62-4·78) deaths associated with AMR in 2019. One pathogen-drug combination, meticillin-resistant S aureus, caused more than 100 000 deaths attributable to AMR in 2019, while six more each caused 50 000-100 000 deaths: multidrug-resistant excluding extensively drug-resistant tuberculosis, third-generation cephalosporin-resistant E coli, carbapenem-resistant A baumannii, fluoroquinolone-resistant E coli, carbapenem-resistant K pneumoniae, and third-generation cephalosporin-resistant K pneumoniae.To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data. AMR is a leading cause of death around the world, with the highest burdens in low-resource settings. Understanding the burden of AMR and the leading pathogen-drug combinations contributing to it is crucial to making informed and location-specific policy decisions, particularly about infection prevention and control programmes, access to essential antibiotics, and research and development of new vaccines and antibiotics. There are serious data gaps in many low-income settings, emphasising the need to expand microbiology laboratory capacity and data collection systems to improve our understanding of this important human health threat.Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
50
100
150
200
250
300
350
400
450
500
|
|
|
Antibiotics
499 публикаций, 4.61%
|
|
|
Frontiers in Microbiology
185 публикаций, 1.71%
|
|
|
JAC-Antimicrobial Resistance
140 публикаций, 1.29%
|
|
|
Microbiology spectrum
138 публикаций, 1.27%
|
|
|
Scientific Reports
138 публикаций, 1.27%
|
|
|
Nature Communications
126 публикаций, 1.16%
|
|
|
Microorganisms
116 публикаций, 1.07%
|
|
|
PLoS ONE
105 публикаций, 0.97%
|
|
|
Journal of Antimicrobial Chemotherapy
94 публикации, 0.87%
|
|
|
Antimicrobial Resistance and Infection Control
83 публикации, 0.77%
|
|
|
ACS Infectious Diseases
81 публикация, 0.75%
|
|
|
Science of the Total Environment
79 публикаций, 0.73%
|
|
|
Journal of Hazardous Materials
78 публикаций, 0.72%
|
|
|
BMC Infectious Diseases
75 публикаций, 0.69%
|
|
|
International Journal of Molecular Sciences
73 публикации, 0.67%
|
|
|
Frontiers in Cellular and Infection Microbiology
71 публикация, 0.66%
|
|
|
Infection and Drug Resistance
70 публикаций, 0.65%
|
|
|
Antimicrobial Agents and Chemotherapy
67 публикаций, 0.62%
|
|
|
International Journal of Antimicrobial Agents
64 публикации, 0.59%
|
|
|
Journal of Medicinal Chemistry
58 публикаций, 0.54%
|
|
|
bioRxiv
58 публикаций, 0.54%
|
|
|
BMC Microbiology
57 публикаций, 0.53%
|
|
|
Journal of Hospital Infection
57 публикаций, 0.53%
|
|
|
Journal of Global Antimicrobial Resistance
57 публикаций, 0.53%
|
|
|
Frontiers in Public Health
56 публикаций, 0.52%
|
|
|
Molecules
54 публикации, 0.5%
|
|
|
European Journal of Medicinal Chemistry
54 публикации, 0.5%
|
|
|
Clinical Infectious Diseases
53 публикации, 0.49%
|
|
|
ACS Omega
51 публикация, 0.47%
|
|
|
50
100
150
200
250
300
350
400
450
500
|
Издатели
|
500
1000
1500
2000
2500
3000
|
|
|
Elsevier
2597 публикаций, 23.98%
|
|
|
Springer Nature
1719 публикаций, 15.87%
|
|
|
MDPI
1208 публикаций, 11.16%
|
|
|
Wiley
615 публикаций, 5.68%
|
|
|
Cold Spring Harbor Laboratory
575 публикаций, 5.31%
|
|
|
Frontiers Media S.A.
534 публикации, 4.93%
|
|
|
American Chemical Society (ACS)
513 публикаций, 4.74%
|
|
|
Oxford University Press
499 публикаций, 4.61%
|
|
|
American Society for Microbiology
394 публикации, 3.64%
|
|
|
Taylor & Francis
378 публикаций, 3.49%
|
|
|
Royal Society of Chemistry (RSC)
236 публикаций, 2.18%
|
|
|
Public Library of Science (PLoS)
192 публикации, 1.77%
|
|
|
BMJ
81 публикация, 0.75%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
81 публикация, 0.75%
|
|
|
Microbiology Society
76 публикаций, 0.7%
|
|
|
Cambridge University Press
53 публикации, 0.49%
|
|
|
SAGE
51 публикация, 0.47%
|
|
|
American Association for the Advancement of Science (AAAS)
50 публикаций, 0.46%
|
|
|
Research Square Platform LLC
41 публикация, 0.38%
|
|
|
Mary Ann Liebert
40 публикаций, 0.37%
|
|
|
F1000 Research
37 публикаций, 0.34%
|
|
|
eLife Sciences Publications
32 публикации, 0.3%
|
|
|
Bentham Science Publishers Ltd.
31 публикация, 0.29%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
29 публикаций, 0.27%
|
|
|
Hindawi Limited
25 публикаций, 0.23%
|
|
|
JMIR Publications
21 публикация, 0.19%
|
|
|
Georg Thieme Verlag KG
19 публикаций, 0.18%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
19 публикаций, 0.18%
|
|
|
Pleiades Publishing
18 публикаций, 0.17%
|
|
|
500
1000
1500
2000
2500
3000
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
11k
Всего цитирований:
10873
Цитирований c 2024:
6963
(64.3%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Murray C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis // The Lancet. 2022. Vol. 399. No. 10325. pp. 629-655.
ГОСТ со всеми авторами (до 50)
Скопировать
Murray C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis // The Lancet. 2022. Vol. 399. No. 10325. pp. 629-655.
Цитировать
RIS
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2022_Murray,
author = {Christopher Jl Murray and Kevin Shunji Ikuta and Fablina Sharara and Lucien Swetschinski and Gisela Robles Aguilar and Authia Gray and Chieh Han and Catherine Bisignano and Puja Rao and Eve Wool and Sarah C Johnson and Annie J Browne and Michael Give Chipeta and Frederick Fell and Sean Hackett and Georgina Haines Woodhouse and Bahar H Kashef Hamadani and Emmanuelle A. P. Kumaran and Barney Mcmanigal and Ramesh Agarwal and Samuel Akech and Samuel Albertson and John Amuasi and Jason Andrews and Aleskandr Aravkin and Elizabeth Ashley and Freddie Bailey and Stephen Baker and Buddha Basnyat and Adrie Bekker and Rose Bender and Bethou Adhisivam and Julia Bielicki and Suppawat Boonkasidecha and James Bukosia and Cristina Carvalheiro and Carlos Castañeda Orjuela and Vilada Chansamouth and Suman Chaurasia and Sara Chiurchiù and Fazle Chowdhury and Aislinn J Cook and Ben Cooper and Tim R. Cressey and Elia Criollo Mora and Matthew Cunningham and Saffiatou Darboe and Nicholas P.J. Day and Maia De Luca and Klara Dokova and others},
title = {Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis},
journal = {The Lancet},
year = {2022},
volume = {399},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/S0140-6736(21)02724-0},
number = {10325},
pages = {629--655},
doi = {10.1016/S0140-6736(21)02724-0}
}
Цитировать
MLA
Скопировать
Murray, Christopher Jl, et al. “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.” The Lancet, vol. 399, no. 10325, Feb. 2022, pp. 629-655. https://doi.org/10.1016/S0140-6736(21)02724-0.